Spastic Cerebral Palsy Clinical Trial
Official title:
Randomized, Double-Blinded Placebo Controlled Trial of Epidural, Sustained-relief Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children
The purpose of this proposal is to improve the investigators' current Selective Dorsal
Rhizotomy (SDR) analgesia protocol by eliminating or minimizing the use of fentanyl in the
post-operative period.
Children undergoing SDR for spastic cerebral palsy have significant post-operative pain. The
procedure requires dissection of the lumbar back musculature and removal of the L1 lamina
(the bony posterior part of the vertebra). The majority of the operation is intradural, and a
water-tight dural closure at the termination of the operation is critical in order to prevent
leakage of cerebrospinal fluid (CSF) from the wound. In fact, these children must remain flat
on their back for 48 hours to allow the dural incision to heal prior to mobilization. Thus,
adequate pain control is essential not only for patient comfort, but also to prevent
agitation and additional stress on the dural closure.
Currently, the investigators' patients undergoing SDR are treated for 48 hours with scheduled
intravenous (IV) narcotic (continuous fentanyl infusion at 0.5-2.0 μg/kg/hour) in addition to
the sedative/muscle relaxant Valium (0.2 mg/kg IV every 4 hours for 24 hours, then every 6
hours for 24 hours). The IV fentanyl, and to a lesser degree Valium, carries a real risk of
hypotension and respiratory depression and requires frequent dose adjustments to achieve
adequate analgesia.
By improving the current SDR analgesia protocol, the investigators hope to maximize patient
safety and comfort while maintaining the effectiveness of the operation by minimizing the
risk of CSF leak.
improve the investigators' current Selective Dorsal Rhizotomy (SDR) analgesia protocol by
eliminating or minimizing the use of fentanyl in the post-operative period.
Children undergoing SDR for spastic cerebral palsy have significant post-operative pain. The
procedure requires dissection of the lumbar back musculature and removal of the L1 lamina
(the bony posterior part of the vertebra). The majority of the operation is intradural, and a
water-tight dural closure at the termination of the operation is critical in order to prevent
leakage of cerebrospinal fluid (CSF) from the wound. In fact, these children must remain flat
on their back for 48 hours to allow the dural incision to heal prior to mobilization. Thus,
adequate pain control is essential not only for patient comfort, but also to prevent
agitation and additional stress on the dural closure.
Currently, the investigators' patients undergoing SDR are treated for 48 hours with scheduled
intravenous (IV) narcotic (continuous fentanyl infusion at 0.5-2.0 μg/kg/hour) in addition to
the sedative/muscle relaxant Valium (0.2 mg/kg IV every 4 hours for 24 hours, then every 6
hours for 24 hours). The IV fentanyl, and to a lesser degree Valium, carries a real risk of
hypotension and respiratory depression and requires frequent dose adjustments to achieve
adequate analgesia.
By improving the current SDR analgesia protocol, the investigators hope to maximize patient
safety and comfort while maintaining the effectiveness of the operation by minimizing the
risk of CSF leak.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Completed |
NCT00011024 -
Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy
|
Phase 2 | |
Recruiting |
NCT05810779 -
Dynamic Surface Exercise and Trunk Targeted Training in Children With Spastic Cerebral Palsy
|
N/A | |
Completed |
NCT01049581 -
Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy
|
N/A | |
Completed |
NCT04634136 -
Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy
|
N/A | |
Recruiting |
NCT06070233 -
Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
|
N/A | |
Completed |
NCT01815814 -
Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy
|
N/A | |
Recruiting |
NCT05113433 -
Effects of Different Time Period of Standing Frame on Spasticity and Gait in Children With Spastic Cerebral Palsy.
|
N/A | |
Recruiting |
NCT03676439 -
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy
|
Phase 2/Phase 3 | |
Completed |
NCT03708757 -
Effect of Post Isometric Relaxation Technique & Eccentric Muscle Contraction on Hamstring Spasticity in CP
|
N/A | |
Not yet recruiting |
NCT03529682 -
Circuit Training in Children With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT06407856 -
Dual Task Training in Spastic Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT06407921 -
Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT06407869 -
Effects of Functional Progressive Strength Training in Children With Spastic Cerebral Palsy
|
N/A | |
Completed |
NCT04078321 -
Evaluation of Multifocal Transcutaneous Electrical Stimulation for Self-treatment Among Children With Cerebral Palsy
|
N/A | |
Active, not recruiting |
NCT06330311 -
Effectiveness of Whole-Body Vibration
|
N/A | |
Completed |
NCT02359799 -
Robotic Rehabilitation of Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT05340439 -
INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)
|
Phase 2 | |
Completed |
NCT01147653 -
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy
|
Phase 2 | |
Recruiting |
NCT04925102 -
Prediction of Recovery in Spastic Cerebral Palsy.
|